133 related articles for article (PubMed ID: 3030763)
1. The effect of chronic captopril therapy on platelet angiotensin II receptor density and vascular responsiveness to angiotensin II infusion.
Kondowe GB; Kelly JG; Copeland S; Johnston GD
Eur J Clin Pharmacol; 1987; 31(5):525-30. PubMed ID: 3030763
[TBL] [Abstract][Full Text] [Related]
2. Renal response to captopril reflects state of local renin system in healthy humans.
Fisher ND; Price DA; Litchfield WR; Williams GH; Hollenberg NK
Kidney Int; 1999 Aug; 56(2):635-41. PubMed ID: 10432403
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans.
Osei SY; Price DA; Fisher ND; Porter L; Laffel LM; Hollenberg NK
Hypertension; 1999 Jan; 33(1 Pt 2):559-64. PubMed ID: 9931165
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
5. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.
Fisher ND; Allan D; Kifor I; Gaboury CL; Williams GH; Moore TJ; Hollenberg NK
Hypertension; 1994 Jan; 23(1):44-51. PubMed ID: 8282330
[TBL] [Abstract][Full Text] [Related]
6. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
7. Kinetic studies of the pharmacologic response to captopril in rats. I. Role of the renin-angiotensin system.
Endoh M; Suzuki M; Katayama K; Kakemi M; Koizumi T
J Pharmacobiodyn; 1989 Jan; 12(1):1-9. PubMed ID: 2542516
[TBL] [Abstract][Full Text] [Related]
8. Dilation of forearm blood vessels after angiotensin-converting-enzyme inhibition by captopril in hypertensive patients.
Johns DW; Ayers CR; Williams SC
Hypertension; 1984; 6(4):545-50. PubMed ID: 6086518
[TBL] [Abstract][Full Text] [Related]
9. The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline.
Kondowe GB; Copeland S; Passmore AP; Leahey WJ; Johnston GD
Eur J Clin Pharmacol; 1987; 32(3):229-35. PubMed ID: 3297732
[TBL] [Abstract][Full Text] [Related]
10. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril.
Heitzer T; Just H; Brockhoff C; Meinertz T; Olschewski M; Münzel T
J Am Coll Cardiol; 1998 Jan; 31(1):83-8. PubMed ID: 9426022
[TBL] [Abstract][Full Text] [Related]
11. Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Saris JJ; van Dijk MA; Kroon I; Schalekamp MA; Danser AH
Hypertension; 2000 Mar; 35(3):764-8. PubMed ID: 10720592
[TBL] [Abstract][Full Text] [Related]
12. Interactions of the systemic and brain renin-angiotensin systems in the control of drinking and the central mediation of pressor responses.
Robinson MM; McLennan GP; Thunhorst RL; Johnson AK
Brain Res; 1999 Sep; 842(1):55-61. PubMed ID: 10526095
[TBL] [Abstract][Full Text] [Related]
13. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
Shepherd AN; Campbell BC; Reid JL
J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
[TBL] [Abstract][Full Text] [Related]
15. Adrenal angiotensin II receptors and vascular reactivity to angiotensin II in the rat during continuous inhibition of angiotensin converting enzyme.
Millar JA; Casey DJ; Johnston CI
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():65s-69s. PubMed ID: 6256119
[TBL] [Abstract][Full Text] [Related]
16. Adenosine activates a vascular renin-angiotensin system in hypertensive subjects.
Taddei S; Virdis A; Favilla S; Salvetti A
Hypertension; 1992 Jun; 19(6 Pt 2):672-5. PubMed ID: 1592466
[TBL] [Abstract][Full Text] [Related]
17. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril.
Wu JN; Edwards D; Berecek KH
Hypertension; 1994 Jun; 23(6 Pt 2):819-22. PubMed ID: 8206610
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects.
Jamerson KA; Nesbitt SD; Amerena JV; Grant E; Julius S
Hypertension; 1996 Apr; 27(4):854-8. PubMed ID: 8613260
[TBL] [Abstract][Full Text] [Related]
19. Vascular angiotensin conversion in humans.
Webb DJ; Collier JG
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S40-4. PubMed ID: 2438489
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II contributes to cerebral vasodilatation during hypoxia in the rabbit.
Maktabi MA; Todd MM; Stachovic G
Stroke; 1995 Oct; 26(10):1871-6. PubMed ID: 7570741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
